University Of Southern California
Clinical trials sponsored by University Of Southern California, explained in plain language.
-
One pill a day? study tests easier Anti-Rejection drug routine
Disease control TerminatedThis study tested whether a simpler, once-daily combination of anti-rejection drugs works as well as the standard twice-daily regimen for people who have received a kidney transplant. Researchers wanted to see if the once-daily schedule could reduce side effects and make it easie…
Phase: PHASE4 • Sponsor: University of Southern California • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
One-Shot radiation during surgery aims to spare breast cancer patients repeat operations
Disease control TerminatedThis study tested whether using special breast scans (mammogram and MRI) before surgery could help doctors better target a single dose of radiation given right after tumor removal. The goal was to see if this one-time treatment during the initial surgery could effectively control…
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Special workouts aim to fix metabolism in cancer survivors
Disease control TerminatedThis study tested whether a specific 4-month exercise program could improve metabolic health in breast and prostate cancer survivors who are overweight and sedentary. Participants were randomly assigned to either the special exercise program or a basic stretching routine. The goa…
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Direct tumor injection trial halted early for advanced cancers
Disease control TerminatedThis early-phase trial tested whether injecting two immune-stimulating drugs directly into tumors could help control advanced cancers, including pancreatic cancer. The goal was to see if this approach could slow tumor growth by rallying the patient's own immune system to attack t…
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Trial halted early: testing combo therapy for tough bladder cancers
Disease control TerminatedThis study tested whether combining the chemotherapy drug docetaxel with the targeted drug lapatinib could help control advanced bladder cancer that had worsened after initial platinum-based chemotherapy. It aimed to see if this combination could slow cancer growth and was safe f…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
Blood test could offer simpler way to spot lung cancer
Diagnosis TerminatedThis study tested whether a simple blood draw, called a 'liquid biopsy,' could accurately diagnose lung cancer. Researchers analyzed blood samples from 51 people who were scheduled for or had recently undergone a standard lung biopsy or scan. The goal was to see if this less inva…
Sponsor: University of Southern California • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC
-
Home comfort care tested to ease suffering for seriously ill
Symptom relief TerminatedThis study aimed to see if bringing specialized comfort care (palliative care) into patients' homes could improve their well-being and reduce hospital visits. It focused on adults with serious conditions like cancer, heart failure, or COPD who were not in hospice. The trial compa…
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
Early cancer drug trial halted after single patient
Knowledge-focused TerminatedThis early-phase study aimed to understand how a new packaging method for an existing chemotherapy drug (paclitaxel) affects immune cells within head and neck cancer tumors. The goal was to gather knowledge to help design future treatments, not to directly treat patients in this …
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC
-
Your fitbit could warn doctors of dangerous side effects
Knowledge-focused TerminatedThis study tested if data from fitness trackers (like Fitbits) could provide a better, more objective way to measure how well cancer patients are functioning. Researchers wanted to see if this data could predict which patients in early-stage drug trials were most likely to experi…
Phase: NA • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC